UBL7 Activators
UBL7 (Ubiquitin-like 7) activators belong to a niche chemical class that interacts with the biochemical pathway involving the protein UBL7, a member of the ubiquitin-like protein family. Ubiquitin-like proteins (UBLs) are known to play a crucial role in a myriad of cellular processes including protein degradation, autophagy, and cell cycle regulation among others. UBL7 is a relatively less characterized member of this family, but it shares the characteristic beta-grasp fold and the ability to form covalent conjugates with target proteins similar to ubiquitin. Activators of UBL7 are molecules designed to modulate the activity of this protein, potentially influencing its interaction with other proteins and its participation in cellular processes. The exact mechanisms by which UBL7 activators exert their influence are complex and involve the fine-tuning of the protein's conformation, stability, and its ability to interface with other components of the cellular machinery.
The study of UBL7 activators is a reflection of the growing interest in the ubiquitin-proteasome system and related UBL pathways, which are fundamental for maintaining cellular homeostasis. Molecular activators that target UBL7 can alter the dynamics of how UBL7 engages with its substrates, possibly affecting the conjugation-deconjugation cycles that determine the fate of proteins marked by UBLs. The interaction of UBL7 activators with their target involves specific binding sites on the protein, which can lead to changes in the overall structure of UBL7, thereby modulating its activity. This can influence the protein's ability to interact with its partners within the cell, including E1-like activating enzymes, E2-like conjugating enzymes, and substrate proteins. Through understanding how UBL7 activators work at the molecular level, a deeper insight into the regulation of the ubiquitin-like protein pathways is obtained, shedding light on the intricate web of protein regulation within the cell.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in various signal transduction pathways. PKC can phosphorylate a multitude of proteins, potentially including UBL7. Phosphorylation of UBL7 may enhance its ubiquitin-like functions and interactions with other proteins in cellular processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels and the subsequent activation of cAMP-dependent protein kinase A (PKA). PKA could then phosphorylate UBL7, which may enhance UBL7's protein modification activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which has downstream effects on various cellular processes, including protein modification systems. Through this pathway, insulin could indirectly enhance the function of UBL7 by modulating the environment in which UBL7 operates. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of serine/threonine phosphatases PP1 and PP2A. Inhibition of these phosphatases can lead to increased phosphorylation levels of various proteins, potentially affecting UBL7 activity by promoting its interaction with phosphorylated substrates or partners. | ||||||
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $300.00 | ||
Calmodulin is a calcium-binding messenger protein that can activate various enzymes and kinases upon calcium signal transduction. This activation may influence the phosphorylation state of proteins within the cell, potentially enhancing UBL7's role in the ubiquitination-like processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, activating calcium-dependent signaling pathways. These pathways can modulate the phosphorylation state of proteins and may indirectly enhance the function of UBL7 by affecting its protein interaction network. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
SNAP releases nitric oxide (NO), which can activate guanylyl cyclase, increasing cGMP levels and influencing protein kinase G (PKG). PKG may affect phosphorylation states within the cell, potentially enhancing the functional activity of UBL7. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can act as allosteric modulators of various enzymes and affect their activity. This modulation could influence pathways in which UBL7 is involved, potentially enhancing its functional role in the cell by affecting the conformation and activity of interacting proteins or enzymes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium ions inhibit glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 could lead to changes in the phosphorylation patterns of proteins, possibly affecting those that interact with or regulate UBL7, thereby enhancing its function in the cell. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits calcineurin, a phosphatase involved in the activation of T-cells. By inhibiting calcineurin, Cyclosporin A could alter phosphorylation states within the cell, which may indirectly enhance the activity of UBL7. | ||||||